Close
Nordic 9Nordic 9

Merleview Capital (investor - Angel Investor)

Ireland merleview.com
See something wrong or missing? Let us know
Offices:Dublin
Average round investment:819k USD
Average number per year:1.0
Distribution: 2024 (1)
Portfolio companies: United Kingdom ŌGI Bio
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Merleview Capital

Name Criteria
United Kingdom Apollo Informal Investment
63%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom CPI Enterprises
63%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Victoria Betoeski
63%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom Edinburgh Technology Fund
62%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland TCS
61%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany ProVeg Incubator
61%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United Kingdom Carbon13
61%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Denmark DTU Innovation
60%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway Erlend Christoffersen
60%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Laboratorios Labiana
60%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top